Ep135: John Maraganore on Developing a New Class of Medicines
The Long Run with Luke Timmerman
00:00
Policy risks and the Inflation Reduction Act
John voices concerns about IRA price negotiation, incentives favoring biologics, and potential harms to innovation.
Play episode from 52:20
Transcript
